# Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

> **NCT02810873** · NA · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 19 (actual)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DEVICE:** Positron Emission Mammography
- **DEVICE:** Positron Emission Tomography
- **RADIATION:** Fludeoxyglucose F-18
- **DRUG:** Copper Cu 64 TP3805

## Key facts

- **NCT ID:** NCT02810873
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-07
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Study terminated by PI
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02810873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02810873, "Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02810873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*